18 November 2024 - The extent to which patients with cancer are willing to accept uncertainty about the clinical benefit of new cancer drugs in exchange for faster access is not known. 

This study aims to examine preferences for access versus certainty, and to understand factors that influence these preferences.

Read The Lancet Oncology article